Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice - PubMed (original) (raw)
Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice
Andrew R Reynolds et al. Cancer Res. 2004.
Abstract
Tumor growth, tumor angiogenesis, and vascular endothelial growth factor (VEGF)-specific angiogenesis are all enhanced in beta(3)-integrin-null mice. Furthermore, endothelial cells isolated from beta(3)-null mice show elevated levels of Flk1 (VEGF receptor 2) expression, suggesting that beta(3)-integrin can control the amplitude of VEGF responses by controlling Flk1 levels or activity. We now show that Flk1 signaling is required for the enhanced tumor growth and angiogenesis seen in beta(3)-null mice. Moreover, beta(3)-null endothelial cells exhibit enhanced migration and proliferation in response to VEGF in vitro, and this phenotype requires Flk1 signaling. Upon VEGF stimulation, beta(3)-null endothelial cells exhibit higher levels of phosphorylated Flk1 and extracellular-related kinases 1 and 2 than wild-type endothelial cells. Furthermore, signaling via ERK1/2 is required to mediate the elevated responses to VEGF observed in beta(3)-null endothelial cells and aortic rings in vitro. These data confirm that VEGF signaling via Flk1 is enhanced in beta(3)-integrin-deficient mice and suggests that this increase may mediate the enhanced angiogenesis and tumor growth observed in these mice in vivo.
Similar articles
- Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. Reynolds LE, et al. Nat Med. 2002 Jan;8(1):27-34. doi: 10.1038/nm0102-27. Nat Med. 2002. PMID: 11786903 - Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J, Blaskovich MA, Jain RK, Delarue F, Paris D, Brem S, Wotoczek-Obadia M, Lin Q, Coppola D, Choi K, Mullan M, Hamilton AD, Sebti SM. Sun J, et al. Cancer Res. 2004 May 15;64(10):3586-92. doi: 10.1158/0008-5472.CAN-03-2673. Cancer Res. 2004. PMID: 15150116 - Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability.
Robinson SD, Reynolds LE, Wyder L, Hicklin DJ, Hodivala-Dilke KM. Robinson SD, et al. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2108-14. doi: 10.1161/01.ATV.0000143857.27408.de. Epub 2004 Sep 2. Arterioscler Thromb Vasc Biol. 2004. PMID: 15345507 - Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I. Stalmans I. Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Verh K Acad Geneeskd Belg. 2005. PMID: 16334858 Review. - Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Rafii S, et al. Nat Rev Cancer. 2002 Nov;2(11):826-35. doi: 10.1038/nrc925. Nat Rev Cancer. 2002. PMID: 12415253 Review. No abstract available.
Cited by
- Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells.
Gavrilovskaya IN, Gorbunova EE, Mackow ER. Gavrilovskaya IN, et al. J Virol. 2010 May;84(9):4832-9. doi: 10.1128/JVI.02405-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181715 Free PMC article. - Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.
Morgan EA, Schneider JG, Baroni TE, Uluçkan O, Heller E, Hurchla MA, Deng H, Floyd D, Berdy A, Prior JL, Piwnica-Worms D, Teitelbaum SL, Ross FP, Weilbaecher KN. Morgan EA, et al. FASEB J. 2010 Apr;24(4):1117-27. doi: 10.1096/fj.09-138420. Epub 2009 Nov 20. FASEB J. 2010. PMID: 19933310 Free PMC article. - Endothelial von Willebrand factor regulates angiogenesis.
Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM. Starke RD, et al. Blood. 2011 Jan 20;117(3):1071-80. doi: 10.1182/blood-2010-01-264507. Epub 2010 Nov 3. Blood. 2011. PMID: 21048155 Free PMC article. - Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner.
Xie L, Duncan MB, Pahler J, Sugimoto H, Martino M, Lively J, Mundel T, Soubasakos M, Rubin K, Takeda T, Inoue M, Lawler J, Hynes RO, Hanahan D, Kalluri R. Xie L, et al. Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9939-44. doi: 10.1073/pnas.1105041108. Epub 2011 May 27. Proc Natl Acad Sci U S A. 2011. PMID: 21622854 Free PMC article. - Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway.
Zhou Y, Bourcy K, Kang YJ. Zhou Y, et al. Cardiovasc Res. 2009 Oct 1;84(1):54-63. doi: 10.1093/cvr/cvp178. Epub 2009 Jun 19. Cardiovasc Res. 2009. PMID: 19542178 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous